Endologix Inc. (ELGX) announced Wednesday that, after a meeting with the FDA, it will conduct a confirmatory clinical study of its Nellix EVAS System. The company now estimates that PMA approval will occur in 2020.
from RTT - Before the Bell http://ift.tt/2qEk7GP
via IFTTT
No comments:
Post a Comment